Outcomes Following GD2-Directed Postconsolidation Therapy for Neuroblastoma After Cessation of Random Assignment on ANBL0032: A Report From the Children's Oncology Group The overall survival and ...

ALLEN, Texas, Dec. 14, 2021 (GLOBE NEWSWIRE) -- PFS (NASDAQ: PFSW), a premier eCommerce order fulfillment provider, has launched a new UK order fulfillment operation for On, a performance running ...

* not calculated for limited sample size. This is an ASCO Meeting Abstract from the 2022 ASCO Genitourinary Cancers Symposium. This abstract does not include a full text component.

Please provide your email address to receive an email when new articles are posted on . Women with advanced ovarian cancer derived significant quality-adjusted PFS benefit from niraparib compared with ...

Shares in Isofol Medical AB dropped by 27% on Dec. 6 as the company informed investors that its ongoing phase III trial of arfolitixorin in metastatic colorectal cancer would not reach the predefined ...

Although ASCT improved PFS in all patients compared to CAR-T therapy, no differences in overall survival were noted between groups.